Holoyohoy, Cuerpo L.
HRN: 25-74-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/22/2024
08/29/2024
IVTT
2.25g
Q6H
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes